Gynecologic Surgery during the COVID-19 Pandemic: Is Universal Screening Mandatory?

Areeruk, Wilasinee; Chiengthong, Keerati; Santibenchakul, Somsook; Oranratanaphan, Shina; Manchana, Tarinee

doi:10.1155/2021/5528334

Cited by 2 publications

(4 citation statements)

References 18 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…15 Results from previous studies on routine preoperative screening did not detect any patients with COVID-19, where pre-procedural swabbing was instituted in combination with self-isolation and the use of questionnaires. 16,17 However, there are also centers that do not practice routine, universal pre-procedural swabbing with rRT-PCR. A single center study from Spain reported that due to low availability, preoperative rRT-PCR tests were only done on 50% of cases during the first period of the study.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Universal COVID-19 pre-procedural swabs in children in a developing country: A comparison of findings over two transmission waves

Tan

Theseira

Zubaidi

et al. 2022

Proceedings of Singapore Healthcare

View full text Add to dashboard Cite

Aim The Coronavirus disease (COVID-19) pandemic has strained healthcare systems worldwide. Some institutions have implemented additional precautionary measures such as pre-procedural swabbing (PPS) to reduce transmission in patients and healthcare workers. We evaluate our experience with universal pre-procedural screening for COVID-19 in low-risk pediatric patients. Methods We performed a retrospective review of patients aged 18 years and below who underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time reverse transcription-polymerase chain reaction (rRT-PCR) assay swabs in our center over two waves (1st May 2020 to 31st July 2020 and 1st April 2021 to 30th June 2021). We included patients who underwent rRT-PCR for SARS-CoV-2 prior to any procedures requiring general anesthesia and were deemed low risk for COVID-19 according to our institutional screening criteria. All study patients were followed up for 14 days post-procedure. Results Of 2065 swabs done for patients aged 18 years and below during the study period, 645 (31.2%) were pre-procedural swabs. Patients were aged 4.2 years (median, interquartile range: 1.6 years–9.8 years). Two patients (0.3%) tested positive for COVID-19 by PPS, detected during Period 2 – both had risk criteria which were overlooked by healthcare workers. Within 14 days post-procedure, 10 patients had unscheduled readmissions and 15 required repeat rRT-PCR, all of which were negative. Conclusions In patients deemed low risk for COVID-19 infection according to our screening criteria, routine pre-procedural swabbing returns a low positive rate. Our findings can guide screening protocols at institutions that provide surgical services during the COVID-19 pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Universal COVID-19 pre-procedural swabs in children in a developing country: A comparison of findings over two transmission waves

Tan

Theseira

Zubaidi

et al. 2022

Proceedings of Singapore Healthcare

View full text Add to dashboard Cite

show abstract

“…Patients undergoing surgery were given priority for nasopharyngeal swab testing for COVID-19 while history and contact racing method was adopted for patients planned for chemotherapy/radiotherapy. 14 Being front-line workers, medical personnel play an important role in effectively treating patients with COVID infection. As of 12 th June 2021, the Indian Medical Association reported that 719 Indian doctors have lost their lives to COVID-19, with the state of Bihar recording the maximum fatalities.…”

Section: Gynecological Cancer Burden In Indiamentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective

Singh

Mishra

Jayraj³

et al. 2022

Cancer Control

View full text Add to dashboard Cite

Management of gynecological cancers has suffered during the pandemic, partly due to lockdown and partly due to directing resources to manage COVID-19 patients. Modification of gynecological cancer management during this pandemic is recommended. Cervical cancer patients who present with stage IA1 disease can have a delay of up to 8 weeks for surgical treatment, considering the slow tumor growth rate. Women with stages IA2, IB1, IB2, IIA1 must undergo radical hysterectomy and lymphadenectomy within 6 to 8 weeks. In areas where surgical treatment is not available, patients should be referred for radiation therapy/areas with adequate surgical expertise. The surgical option is attractive for early cancers during the COVID era, as it involves a single visit compared to the multiple visits required for chemoradiation. The value of lymph node staging needs to be reconsidered. Neoadjuvant chemotherapy should be given preference over primary cytoreductive surgery for advanced ovarian cancers. Surgeries, which demand extended surgical time such as Hyperthermic Intraperitoneal Chemotherapy and pelvic exenterations, should be avoided during this pandemic. For patients scheduled for interval surgery after two or three neoadjuvant cycles, six cycles of chemotherapy should be considered before surgery is performed. For early-stage, low-grade endometrial cancer, consideration should be given to medical management until surgery is possible. The above recommendations have been made keeping in mind the geography, patient load, and availability of resources available to health care providers from southeast Asia. They might not be applicable globally and every practitioner should take call regarding patient’s management as per availability of resources and loco-regional circumstances. The implementation of recommended international guidelines for the management of gynecologic cancers should take precedence. Each modification to the standard approach should be approved by a multidisciplinary team depending on the condition of the patients and the locoregional circumstances.

show abstract

Gynecologic Surgery during the COVID-19 Pandemic: Is Universal Screening Mandatory?

Cited by 2 publications

References 18 publications

Universal COVID-19 pre-procedural swabs in children in a developing country: A comparison of findings over two transmission waves

Universal COVID-19 pre-procedural swabs in children in a developing country: A comparison of findings over two transmission waves

Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective

Contact Info

Product

Resources

About